http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0747092-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30 |
| filingDate | 1996-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_664dfe59aef54646fe1b8e686fec2389 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e4f5093c4bd19f27f962226f3e3d279 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb7813ef516fa16b25b3ec8f0f2ca9b |
| publicationDate | 1998-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0747092-A3 |
| titleOfInvention | Dissolution liquid for drug in iontophoresis |
| abstract | A drug held or supported by an interface comprising anporous matrix is dissolved with a drug dissolution liquidncontaining a humectant, and the drug is transdermallyndelivered by iontophoresis. The humectant includesne.g. glycerin and other polyhydric alcohols,nsugar alcohols, proline and other amino acids and acidicnmucopolysaccharides. The concentration of the humectantnmay be about 1 to 50% by weight, and the concentrationnof proline or other amino acid or its salt may be aboutn1 to 30% by weight. The drug includes (1) a physiologicallynactive peptide or protein with a molecular weightnof 100 to 30,000 or (2) a nonpeptide physiologicallynactive compound with a molecular weight of 100 to 1,000. |
| priorityDate | 1995-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.